ZA952269B - Antibody conjugates with improved properties - Google Patents
Antibody conjugates with improved propertiesInfo
- Publication number
- ZA952269B ZA952269B ZA952269A ZA952269A ZA952269B ZA 952269 B ZA952269 B ZA 952269B ZA 952269 A ZA952269 A ZA 952269A ZA 952269 A ZA952269 A ZA 952269A ZA 952269 B ZA952269 B ZA 952269B
- Authority
- ZA
- South Africa
- Prior art keywords
- improved properties
- antibody conjugates
- conjugates
- antibody
- properties
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94810173 | 1994-03-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA952269B true ZA952269B (en) | 1995-09-21 |
Family
ID=8218230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA952269A ZA952269B (en) | 1994-03-21 | 1995-03-20 | Antibody conjugates with improved properties |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPH0820545A (xx) |
KR (1) | KR950031111A (xx) |
AU (1) | AU1481795A (xx) |
CA (1) | CA2144936A1 (xx) |
FI (1) | FI951276A (xx) |
HU (1) | HUT71776A (xx) |
IL (1) | IL113022A (xx) |
NO (1) | NO951061L (xx) |
NZ (1) | NZ270734A (xx) |
RU (1) | RU95104325A (xx) |
ZA (1) | ZA952269B (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2865737B1 (fr) * | 2004-02-03 | 2006-03-31 | Anteis Sa | Gel reticule biocompatible |
-
1995
- 1995-02-24 HU HU9500586A patent/HUT71776A/hu unknown
- 1995-03-14 AU AU14817/95A patent/AU1481795A/en not_active Abandoned
- 1995-03-17 FI FI951276A patent/FI951276A/fi unknown
- 1995-03-17 JP JP7059022A patent/JPH0820545A/ja active Pending
- 1995-03-17 IL IL11302295A patent/IL113022A/xx not_active IP Right Cessation
- 1995-03-17 RU RU95104325/14A patent/RU95104325A/ru unknown
- 1995-03-17 CA CA002144936A patent/CA2144936A1/en not_active Abandoned
- 1995-03-17 NZ NZ270734A patent/NZ270734A/en unknown
- 1995-03-20 NO NO951061A patent/NO951061L/no unknown
- 1995-03-20 ZA ZA952269A patent/ZA952269B/xx unknown
- 1995-03-20 KR KR1019950005739A patent/KR950031111A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU95104325A (ru) | 1996-12-27 |
KR950031111A (ko) | 1995-12-18 |
FI951276A (fi) | 1995-09-22 |
IL113022A0 (en) | 1995-06-29 |
IL113022A (en) | 2000-02-29 |
CA2144936A1 (en) | 1995-09-22 |
AU1481795A (en) | 1995-09-28 |
NO951061D0 (no) | 1995-03-20 |
FI951276A0 (fi) | 1995-03-17 |
HU9500586D0 (en) | 1995-04-28 |
JPH0820545A (ja) | 1996-01-23 |
HUT71776A (en) | 1996-01-29 |
NO951061L (no) | 1995-09-22 |
NZ270734A (en) | 1997-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9422383D0 (en) | Antibodies | |
TJ328B (en) | Interferron conjugates | |
PL330111A1 (en) | Concentyratyed antibody preparation | |
EP1073464A4 (en) | MONOCLONAL ANTIBODIES WITH REDUCED IMMUNIZABILITY | |
GB9603256D0 (en) | Antibodies | |
GB9809839D0 (en) | Antibody | |
EP0765166A4 (en) | RADIOACTIVELY MARKED ANNEXIN GALACTOSE CONJUGATES | |
IL116456A0 (en) | Oligonucleotide-dendrimer conjugates | |
GB9828700D0 (en) | Antibody | |
IL113022A (en) | Antibody conjugates with improved properties | |
IL98777A0 (en) | Antibody conjugates | |
GB9419256D0 (en) | Antibody and conjugates | |
ZA9510827B (en) | Oligonucleotide-dendrimer conjugates | |
HU9501990D0 (en) | Rapamycin conjugates and antibodies | |
GB9021210D0 (en) | Antigen-antibody conjugates | |
ZA954678B (en) | Monoclonal antibody against cd44v6 | |
GB9406243D0 (en) | Antibodies | |
IL134049A0 (en) | Anti-cryptdin antibodies | |
GB9406222D0 (en) | Huminised antibodies | |
GB9415331D0 (en) | Antibodies | |
GB9406244D0 (en) | Altered antibodies | |
GB9401597D0 (en) | Altered antibodies | |
GB9404300D0 (en) | Antibodies with improved effector function | |
GB9110444D0 (en) | Antigen-antibody conjugates ii | |
GB9402593D0 (en) | Antibody fragments |